05/10/2024
3:35 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:04 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:10 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
3:17 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
8:11 AM | Entrada Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
8:13 AM | Entrada Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
8:14 AM | Entrada Therapeutics (Filer)
| Form ARS | |
|
04/25/2024
3:30 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024
3:20 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/23/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 AM | Entrada Therapeutics (Filer)
| Form PRE 14A | |
04/18/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:16 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
3:23 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:35 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:14 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:12 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
4:16 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
3:17 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
3:31 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
4:57 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:31 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:33 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:36 AM | Entrada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
6:24 AM | Entrada Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
3:34 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:36 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:22 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:22 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:44 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:46 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:47 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:48 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:37 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:19 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:32 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:16 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:35 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:38 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Your Portfolio’s Shield Against Inflation: Gold’s Surge and AI Breakthroughs (Ad) While gold may be thanking China for its recent growth, this sector is currently thanking Elon Musk.
As crazy as it sounds, artificial intelligence just got one step closer to ushering in "the next step in human evolution"... and minting new millionaires.
And it's all thanks to Musk's latest AI creation. Click to watch this device in action |
12/21/2023
3:26 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
3:40 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
4:25 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
4:24 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:38 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
4:14 PM | Crowley John F (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
6:00 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
6:35 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
3:35 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2023
6:20 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
6:01 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/19/2023
4:27 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:35 PM | Entrada Therapeutics (Filer)
| Form 424B5 | |
09/29/2023
3:39 PM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2023
6:09 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/15/2023
3:21 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:07 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:08 PM | Entrada Therapeutics (Issuer)
KREHER NERISSA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
4:09 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:31 PM | Chapman Gina (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:32 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
6:09 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:23 AM | Entrada Therapeutics (Filer)
| Form 10-K/A | |
08/08/2023
6:25 AM | Entrada Therapeutics (Filer)
| Form 10-Q/A | |
08/08/2023
6:07 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
6:14 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
6:08 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:32 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:33 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:34 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
3:11 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2023
3:12 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/30/2023
3:32 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:20 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:46 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:12 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
3:18 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
3:27 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:11 PM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
